ppanPersonalized Psychiatry and NeurologyPersonalized Psychiatry and Neurology2712-9179V. M. Bekhterev National Medical Research Centre for Psychiatry and Neurology of the Ministry of Health of the Russian Federation (Bekhterev NMRC PN)10.52667/2712-9179-2022-2-2-47-56ppan-51Research ArticleREVIEWModifiable and Non-Modifiable Predictors of Dupuytren’s DiseasePetrovA. V.

Artem V. Petrov

660022, Krasnoyarsk

Tel.: +7(923)575-80-96

artvpetrov@mail.ruMedvedevG. V.

German V. Medvedev

St. Petersburg

PushkinD. V.

Denis V. Pushkin, Faculty of Medicine

St. Petersburg

RodomanovaL. A.

Lyubov A. Rodomanova

St. Petersburg

PetrovaM. M.

Marina M. Petrova

660022, Krasnoyarsk

V.F. Voino-Yasenetsky Krasnoyarsk State Medical UniversityRussian FederationR.R. Vreden National Medical Research Center for Traumatology and OrthopedicsRussian FederationSt. Petersburg State UniversityRussian Federation202215112022224756Copyright © Petrov A.V., Medvedev G.V., Pushkin D.V., Rodomanova L.A., Petrova M.M., 20222022Petrov A.V., Medvedev G.V., Pushkin D.V., Rodomanova L.A., Petrova M.M.Petrov A.V., Medvedev G.V., Pushkin D.V., Rodomanova L.A., Petrova M.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jppn.ru/jour/article/view/51

Dupuytren's disease (DD) is a common multifactorial disease accompanied by deformity of the hand with flexion contracture of one or more fingers, limitation of their mobility and a fixed lesion. This disease refers to disorders of the connective tissue. Objective: to generalize the results of studies of environmental risk factors for DD and update existing ideas about modifiable and non-modifiable predictors of the disease in adults. Methods. We searched for full-text English-language publications in the PubMed, Springer, Scopus, Clinical Keys, Oxford Press, Google Scholar, eLIBRARY. Results. The most significant modifiable predictors of the development of DD include (top 5): occupation; hobby; lifestyle; comorbid diseases; drugs. Non-modifiable predictors include (top 5): gender; age; ethnos; race; genetics. Genetic predictors of DD are not well understood, but the number of candidate genes responsible for the development of DD is increasing and reaches the top 50 or more candidate genes with a statistically significant association with the risk of developing DD in adults. The most studied candidate genes are DUPC1, MMP2, MMP9, TIMP1, TIMP2, WNT4, WNT7B. Discussion. Primary and secondary prevention of DD requires accounting of the mutual influence of modifiable and non-modifiable predictors in the disease development, as well as a personalized approach in planning and choosing non-surgical and surgical treatment, as well as the carriage of single nucleotide variants (SNVs) candidate genes associated with the development of DD. A promising direction in the prevention of disabling complications of DD may be the development of decision-making information programs (personalized algorithms) that take into account non-genetic and genetic predictors in a particular person, and their implementation in real clinical practice. Conclusion. Large multicenteral studies of the influence and mutual influence of modifiable and non-modifiable predictors with a single design are required in the future.

Dupuytren's contractureDupuytren's diseaseViking diseasesclerosing ligamentitisrisk factorReferencesMichou, L.; Lermusiaux, J.L.; Teyssedou, J.P.; Bardin, T.; Beaudreuil, J.; Petit-Teixeira, E. Genetics of Dupuytren's disease. Joint Bone Spine 2012, 79(1), 7-12. https://doi.org/10.1016/j.jbspin.2011.05.027.Michou, L.; Lermusiaux, J.L.; Teyssedou, J.P.; Bardin, T.; Beaudreuil, J.; Petit-Teixeira, E. Genetics of Dupuytren's disease. Joint Bone Spine 2012, 79(1), 7-12. https://doi.org/10.1016/j.jbspin.2011.05.027.Alencar, F.H.U.; Perini, J.A.; Monteiro, A.V.; Duarte, M.E.L.; Motta, G.D.R.; Guimarães, J.A.M. Epidemiology of Dupuytren disease and Patients Undergoing Selective Fasciectomy. Rev. Bras. Ortop. (Sao Paulo) 2021, 56(4), 478-484. https://doi.org/10.1055/s-0040-1721839.Alencar, F.H.U.; Perini, J.A.; Monteiro, A.V.; Duarte, M.E.L.; Motta, G.D.R.; Guimarães, J.A.M. Epidemiology of Dupuytren disease and Patients Undergoing Selective Fasciectomy. Rev. Bras. Ortop. (Sao Paulo) 2021, 56(4), 478-484. https://doi.org/10.1055/s-0040-1721839.Wilbrand S. 2002. Dupuytren´s contracture - features and consequences. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1130. 53 pp. Uppsala. ISBN 91-554-5262-0.Wilbrand S. 2002. Dupuytren´s contracture - features and consequences. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1130. 53 pp. Uppsala. ISBN 91-554-5262-0.Loos, B.; Puschkin, V.; Horch, R.E. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital-a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet. Disord. 2007, 8, 60. https://doi.org/10.1186/1471-2474-8-60.Loos, B.; Puschkin, V.; Horch, R.E. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital-a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet. Disord. 2007, 8, 60. https://doi.org/10.1186/1471-2474-8-60.Rayan, G. Dupuytren´s disease. Hand Surgery 1999, 236-271.Rayan, G. Dupuytren´s disease. Hand Surgery 1999, 236-271.Hueston, J.T. Dupuytren´s diathesis. In Dupuytren´s disease, McFarlane RM, McGrouther DA, Flint MH, editors. Edinburgh: Churchill Livingstone, 1990, 247 pp.Hueston, J.T. Dupuytren´s diathesis. In Dupuytren´s disease, McFarlane RM, McGrouther DA, Flint MH, editors. Edinburgh: Churchill Livingstone, 1990, 247 pp.Hu, F.Z.; Nystrom, A.; Ahmed, A.; Palmquist, M.; Dopico, R.; Mossberg, I.; Gladitz, J.; Rayner, M.; Post, J.C.; Ehrlich, G.D.; Preston, R.A. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin. Genet. 2005, 68, 424-429. https://pubmed.ncbi.nlm.nih.gov/16207209.Hu, F.Z.; Nystrom, A.; Ahmed, A.; Palmquist, M.; Dopico, R.; Mossberg, I.; Gladitz, J.; Rayner, M.; Post, J.C.; Ehrlich, G.D.; Preston, R.A. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin. Genet. 2005, 68, 424-429. https://pubmed.ncbi.nlm.nih.gov/16207209.Rodrigues, J.N.; Becker, G.W.; Ball, C.; Zhang, W.; Giele, H.; Hobby, J.; Pratt, A.L.; Davis, T. Surgery for Dupuytren's contracture of the fingers. Cochrane Database Syst. Rev. 2015, 2015(12), CD010143. https://doi.org/10.1002/14651858.CD010143.pub2.Rodrigues, J.N.; Becker, G.W.; Ball, C.; Zhang, W.; Giele, H.; Hobby, J.; Pratt, A.L.; Davis, T. Surgery for Dupuytren's contracture of the fingers. Cochrane Database Syst. Rev. 2015, 2015(12), CD010143. https://doi.org/10.1002/14651858.CD010143.pub2.Goldblum, J.R.; Folpe, A.L.; Weiss, S.W. Benign fibroblastic/myofibroblastic proliferations, including superficial fibromatoses. Enzinger and Weiss's Soft Tissue Tumors. 6thed. Philadelphia: Elsevier Saunders, 2014, pp. 188–255.Goldblum, J.R.; Folpe, A.L.; Weiss, S.W. Benign fibroblastic/myofibroblastic proliferations, including superficial fibromatoses. Enzinger and Weiss's Soft Tissue Tumors. 6thed. Philadelphia: Elsevier Saunders, 2014, pp. 188–255.Görlach, A.; Dimova, E.Y.; Petry, A.; Martínez-Ruiz, A.; Hernansanz-Agustín, P.; Rolo, A.P.; Palmeira, C.M.; Kietzmann, T. Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? Redox Biol. 2015, 6, 372-385. https://doi.org/10.1016/j.redox.2015.08.016.Görlach, A.; Dimova, E.Y.; Petry, A.; Martínez-Ruiz, A.; Hernansanz-Agustín, P.; Rolo, A.P.; Palmeira, C.M.; Kietzmann, T. Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? Redox Biol. 2015, 6, 372-385. https://doi.org/10.1016/j.redox.2015.08.016.Ulrich, D.; Ulrich, F.; Piatkowski, A.; Pallua, N. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. Arch. Orthop. Trauma Surg. 2009, 129(11), 1453-1459. https://doi.org/10.1007/s00402-008-0726-3.Ulrich, D.; Ulrich, F.; Piatkowski, A.; Pallua, N. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. Arch. Orthop. Trauma Surg. 2009, 129(11), 1453-1459. https://doi.org/10.1007/s00402-008-0726-3.Qian, A.; Meals, R.A.; Rajfer, J.; Gonzalez-Cadavid, N.F. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 2004, 64(2), 399-404. https://doi.org/10.1016/j.urology.2004.04.006.Qian, A.; Meals, R.A.; Rajfer, J.; Gonzalez-Cadavid, N.F. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 2004, 64(2), 399-404. https://doi.org/10.1016/j.urology.2004.04.006.Layton, T.; Nanchahal, J. Recent advances in the understanding of Dupuytren's disease. F1000Res. 2019, 8(F1000 Faculty Rev), 231. https://doi.org/10.12688/f1000research.17779.1.Layton, T.; Nanchahal, J. Recent advances in the understanding of Dupuytren's disease. F1000Res. 2019, 8(F1000 Faculty Rev), 231. https://doi.org/10.12688/f1000research.17779.1.Wick, G.; Grundtman, C.; Mayerl, C.; Wimpissinger, T.F.; Feichtinger, J.; Zelger, B.; Sgonc, R.; Wolfram, D. The immunology of fibrosis. Annu. Rev. Immunol. 2013, 31, 107-135. https://doi.org/10.1146/annurev-immunol-032712-095937.Wick, G.; Grundtman, C.; Mayerl, C.; Wimpissinger, T.F.; Feichtinger, J.; Zelger, B.; Sgonc, R.; Wolfram, D. The immunology of fibrosis. Annu. Rev. Immunol. 2013, 31, 107-135. https://doi.org/10.1146/annurev-immunol-032712-095937.Wynn, T.A.; Ramalingam, T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18(7), 1028- 1040. https://doi.org/10.1038/nm.2807.Wynn, T.A.; Ramalingam, T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18(7), 1028- 1040. https://doi.org/10.1038/nm.2807.Ten Dam, E.J.; van Beuge, M.M.; Bank, R.A.; Werker, P.M. Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease. J. Cell Commun. Signal. 2016, 10(1), 33-40. https://doi.org/10.1007/s12079-015-0312-8.Ten Dam, E.J.; van Beuge, M.M.; Bank, R.A.; Werker, P.M. Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease. J. Cell Commun. Signal. 2016, 10(1), 33-40. https://doi.org/10.1007/s12079-015-0312-8.Dolmans, G.H.; Werker, P.M.; Hennies, H.C.; Furniss, D.; Festen, E.A.; Franke, L.; Becker, K.; van der Vlies, P.; Wolffenbuttel, B.H.; Tinschert, S.; Toliat, M.R.; Nothnagel, M.; Franke, A.; Klopp, N.; Wichmann, H.-E.; Nürnberg, P.; Giele, H.; Ophoff, R.A.; Wijmenga, C. Wnt signaling and Dupuytren's disease. N. Engl. J. Med. 2011, 365(4), 307-317. https://doi.org/10.1056/NEJMoa1101029.Dolmans, G.H.; Werker, P.M.; Hennies, H.C.; Furniss, D.; Festen, E.A.; Franke, L.; Becker, K.; van der Vlies, P.; Wolffenbuttel, B.H.; Tinschert, S.; Toliat, M.R.; Nothnagel, M.; Franke, A.; Klopp, N.; Wichmann, H.-E.; Nürnberg, P.; Giele, H.; Ophoff, R.A.; Wijmenga, C. Wnt signaling and Dupuytren's disease. N. Engl. J. Med. 2011, 365(4), 307-317. https://doi.org/10.1056/NEJMoa1101029.Elosegui-Artola, A.; Oria, R.; Chen, Y.; Kosmalska, A.; Pérez-González, C.; Castro, N.; Zhu, C.; Trepat, X.; Roca-Cusachs, P. Mechanical regulation of a molecular clutch defines force transmission and transduction in response to matrix rigidity. Nat. Cell Biol. 2016, 18, 540–548. https://doi.org/10.1038/ncb3336.Elosegui-Artola, A.; Oria, R.; Chen, Y.; Kosmalska, A.; Pérez-González, C.; Castro, N.; Zhu, C.; Trepat, X.; Roca-Cusachs, P. Mechanical regulation of a molecular clutch defines force transmission and transduction in response to matrix rigidity. Nat. Cell Biol. 2016, 18, 540–548. https://doi.org/10.1038/ncb3336.Dupont, S.; Morsut, L.; Aragona, M.; Enzo, E.; Giulitti, S.; Cordenonsi, M.; Zanconato, F.; Digabel, J.L.; Forcato, M.; Bicciato, S.; Elvassore, N.; Piccolo, S. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474(7350), 179-183. https://doi.org/10.1038/nature10137.Dupont, S.; Morsut, L.; Aragona, M.; Enzo, E.; Giulitti, S.; Cordenonsi, M.; Zanconato, F.; Digabel, J.L.; Forcato, M.; Bicciato, S.; Elvassore, N.; Piccolo, S. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474(7350), 179-183. https://doi.org/10.1038/nature10137.Jorgenson, A.J.; Choi, K.M.; Sicard, D.; Smith, K.M.; Hiemer, S.E.; Varelas, X.; Tschumperlin, D.J. TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression. Am. J. Physiol. Cell Physiol. 2017, 312(3), 277-285. https://doi.org/10.1152/ajpcell.00205.2016.Jorgenson, A.J.; Choi, K.M.; Sicard, D.; Smith, K.M.; Hiemer, S.E.; Varelas, X.; Tschumperlin, D.J. TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression. Am. J. Physiol. Cell Physiol. 2017, 312(3), 277-285. https://doi.org/10.1152/ajpcell.00205.2016.Tomasek, J.J.; Vaughan, M.B.; Haaksma, C.J. Cellular structure and biology of Dupuytren's disease. Hand Clin. 1999, 15(1), 21- 34. https://pubmed.ncbi.nlm.nih.gov/10050239.Tomasek, J.J.; Vaughan, M.B.; Haaksma, C.J. Cellular structure and biology of Dupuytren's disease. Hand Clin. 1999, 15(1), 21- 34. https://pubmed.ncbi.nlm.nih.gov/10050239.Mosakhani, N.; Guled, M.; Lahti, L.; Borze, I.; Forsman, M.; Pääkkönen, V.; Ryhänen, J.; Knuutila, S. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway. Mod. Pathol. 2010, 23(11), 1544-1552. https://doi.org/10.1038/modpathol.2010.146.Mosakhani, N.; Guled, M.; Lahti, L.; Borze, I.; Forsman, M.; Pääkkönen, V.; Ryhänen, J.; Knuutila, S. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway. Mod. Pathol. 2010, 23(11), 1544-1552. https://doi.org/10.1038/modpathol.2010.146.McFarlane, R.M. Patterns of the diseased fascia in the fingers in Dupuytren's contracture. Displacement of the neurovascular bundle. Plast. Reconstr. Surg. 1974, 54(1), 31-44. https://doi.org/10.1097/00006534-197407000-00004.McFarlane, R.M. Patterns of the diseased fascia in the fingers in Dupuytren's contracture. Displacement of the neurovascular bundle. Plast. Reconstr. Surg. 1974, 54(1), 31-44. https://doi.org/10.1097/00006534-197407000-00004.Bayat, A.; Al-Himdani, S. The cell biology of Dupuytren’s Disease. In: Handchirurgie Weltweit e.V., Böttcher, R., editors. Living Textbook of Hand Surgery. Cologne: GMS; 2014. https://doi.org/10.5680/lhhs000012.Bayat, A.; Al-Himdani, S. The cell biology of Dupuytren’s Disease. In: Handchirurgie Weltweit e.V., Böttcher, R., editors. Living Textbook of Hand Surgery. Cologne: GMS; 2014. https://doi.org/10.5680/lhhs000012.Hueston J. The role of the skin in Dupuytren's disease. Ann. R. Coll. Surg. Engl. 1985, 67(6), 372-375. https://pubmed.ncbi.nlm.nih.gov/3907476.Hueston J. The role of the skin in Dupuytren's disease. Ann. R. Coll. Surg. Engl. 1985, 67(6), 372-375. https://pubmed.ncbi.nlm.nih.gov/3907476.Gosset, J. Dupuytren’s disease and the anatomy of the palmo-digital aponeuroses. In: Hueston, J.T., Tubiana, R., editors. Dupuytren's Disease. 2nd ed. Edinburgh: Churchill-Livingstone 1985; pp. 13-26.Gosset, J. Dupuytren’s disease and the anatomy of the palmo-digital aponeuroses. In: Hueston, J.T., Tubiana, R., editors. Dupuytren's Disease. 2nd ed. Edinburgh: Churchill-Livingstone 1985; pp. 13-26.Strickland, J.W.; Leibovic, S.J. Anatomy and pathogenesis of the digital cords and nodules. Hand clinics 1991, 7(4), 645-657. https://pubmed.ncbi.nlm.nih.gov/1769987.Strickland, J.W.; Leibovic, S.J. Anatomy and pathogenesis of the digital cords and nodules. Hand clinics 1991, 7(4), 645-657. https://pubmed.ncbi.nlm.nih.gov/1769987.Murrell, G.A. An insight into Dupuytren's contracture. Ann. R. Coll. Surg. Engl. 1992; 74(3): 156-161. https://pubmed.ncbi.nlm.nih.gov/1616255.Murrell, G.A. An insight into Dupuytren's contracture. Ann. R. Coll. Surg. Engl. 1992; 74(3): 156-161. https://pubmed.ncbi.nlm.nih.gov/1616255.Andrew, J.G.; Andrew, S.M.; Ash, A.; Turner, B. An investigation into the role of inflammatory cells in Dupuytren's disease. J. Hand Surg. Br. 1991, 16(3), 267-271. https://doi.org/10.1016/0266-7681(91)90051-o.Andrew, J.G.; Andrew, S.M.; Ash, A.; Turner, B. An investigation into the role of inflammatory cells in Dupuytren's disease. J. Hand Surg. Br. 1991, 16(3), 267-271. https://doi.org/10.1016/0266-7681(91)90051-o.Morelli, I.; Fraschini, G.; Banfi, A.E. Dupuytren's Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case-Control Study. Arch. Bone Jt. Surg. 2017, 5(6), 384-393. https://pubmed.ncbi.nlm.nih.gov/29299493.Morelli, I.; Fraschini, G.; Banfi, A.E. Dupuytren's Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case-Control Study. Arch. Bone Jt. Surg. 2017, 5(6), 384-393. https://pubmed.ncbi.nlm.nih.gov/29299493.Strafun, S.S.; Urovsky, O.O. Dupuytren’s contracture relapse and factors affecting it when applying operational method of treatment. TRAUMA 2013, 14(6), 109-113. https://doi.org/10.22141/1608-1706.6.14.2013.87839.Strafun, S.S.; Urovsky, O.O. Dupuytren’s contracture relapse and factors affecting it when applying operational method of treatment. TRAUMA 2013, 14(6), 109-113. https://doi.org/10.22141/1608-1706.6.14.2013.87839.Ball, C.; Izadi, D.; Verjee, L.S.; Chan, J.; Nanchahal, J. Systematic review of non-surgical treatments for early Dupuytren's disease. BMC Musculoskelet. Disord. 2016, 17(1), 345. https://doi.org/10.1186/s12891-016-1200-y.Ball, C.; Izadi, D.; Verjee, L.S.; Chan, J.; Nanchahal, J. Systematic review of non-surgical treatments for early Dupuytren's disease. BMC Musculoskelet. Disord. 2016, 17(1), 345. https://doi.org/10.1186/s12891-016-1200-y.Europe PMC. Available online: https://europepmc.org/article/pmc/5736887#R2 (accessed on 20 August 2022).Europe PMC. Available online: https://europepmc.org/article/pmc/5736887#R2 (accessed on 20 August 2022).Descatha, A.; Bodin, J.; Ha, C.; Goubault, P.; Lebreton, M.; Chastang, J.F.; Imbernon, E.; Leclerc, A.; Goldberg, M.; Roquelaure, Y. Heavy manual work, exposure to vibration and Dupuytren's disease? Results of a surveillance program for musculoskeletal disorders. Occup. Environ. Med. 2012, 69(4), 296-299. https://doi.org/10.1136/oemed-2011-100319.Descatha, A.; Bodin, J.; Ha, C.; Goubault, P.; Lebreton, M.; Chastang, J.F.; Imbernon, E.; Leclerc, A.; Goldberg, M.; Roquelaure, Y. Heavy manual work, exposure to vibration and Dupuytren's disease? Results of a surveillance program for musculoskeletal disorders. Occup. Environ. Med. 2012, 69(4), 296-299. https://doi.org/10.1136/oemed-2011-100319.Palmer, K.T.; D'Angelo, S.; Syddall, H.; Griffin, M.J.; Cooper, C.; Coggon, D. Dupuytren's contracture and occupational exposure to hand-transmitted vibration. Occup. Environ. Med. 2014, 71(4), 241-245. https://doi.org/10.1136/oemed-2013-101981.Palmer, K.T.; D'Angelo, S.; Syddall, H.; Griffin, M.J.; Cooper, C.; Coggon, D. Dupuytren's contracture and occupational exposure to hand-transmitted vibration. Occup. Environ. Med. 2014, 71(4), 241-245. https://doi.org/10.1136/oemed-2013-101981.Murínová, L.; Perečinský, S.; Jančová, A.; Murín, P.; Legáth, Ľ. Is Dupuytren's disease an occupational illness? Occup. Med. (Lond.) 2021, 71(1), 28-33. https://doi.org/10.1093/occmed/kqaa211.Murínová, L.; Perečinský, S.; Jančová, A.; Murín, P.; Legáth, Ľ. Is Dupuytren's disease an occupational illness? Occup. Med. (Lond.) 2021, 71(1), 28-33. https://doi.org/10.1093/occmed/kqaa211.Beleta, H.; Forés, J. Dupuytren's disease in a rock climber with an unaffected identical twin. J. Hand Surg. Eur. Vol. 2014, 39(3), 313-314. https://doi.org/10.1177/1753193412457149.Beleta, H.; Forés, J. Dupuytren's disease in a rock climber with an unaffected identical twin. J. Hand Surg. Eur. Vol. 2014, 39(3), 313-314. https://doi.org/10.1177/1753193412457149.Lurati, A.R. Dupuytren’s Contracture: Work-Related Disorder? Workplace Health & Safety 2017, 65(3), 96-99. https://doi.org/10.1177/2165079916680215.Lurati, A.R. Dupuytren’s Contracture: Work-Related Disorder? Workplace Health & Safety 2017, 65(3), 96-99. https://doi.org/10.1177/2165079916680215.Degreef, I. Comorbidity in Dupuytren disease. Acta Orthop. Belg. 2016, 82(3), 643-648. https://pubmed.ncbi.nlm.nih.gov/29119908.Degreef, I. Comorbidity in Dupuytren disease. Acta Orthop. Belg. 2016, 82(3), 643-648. https://pubmed.ncbi.nlm.nih.gov/29119908.Hindocha, S.; Stanley, J.K.; Watson, S.; Bayat, A. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J. Hand Surg. Am. 2006, 31(10), 1626-1634. https://doi.org/10.1016/j.jhsa.2006.09.006.Hindocha, S.; Stanley, J.K.; Watson, S.; Bayat, A. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J. Hand Surg. Am. 2006, 31(10), 1626-1634. https://doi.org/10.1016/j.jhsa.2006.09.006.Nugteren, H.M.; Nijman, J.M.; de Jong, I.J.; van Driel, M.F. The association between Peyronie's and Dupuytren's disease. Int. J. Impot. Res. 2011, 23(4), 142-145. https://doi.org/10.1038/ijir.2011.18.Nugteren, H.M.; Nijman, J.M.; de Jong, I.J.; van Driel, M.F. The association between Peyronie's and Dupuytren's disease. Int. J. Impot. Res. 2011, 23(4), 142-145. https://doi.org/10.1038/ijir.2011.18.Descatha, A.; Carton, M.; Mediouni, Z.; Dumontier, C.; Roquelaure, Y.; Goldberg, M.; Zins, M.; Leclerc, A. Association among work exposure, alcohol intake, smoking and Dupuytren's disease in a large cohort study (GAZEL). BMJ Open 2014, 4(1), e004214. https://doi.org/10.1136/bmjopen-2013-004214.Descatha, A.; Carton, M.; Mediouni, Z.; Dumontier, C.; Roquelaure, Y.; Goldberg, M.; Zins, M.; Leclerc, A. Association among work exposure, alcohol intake, smoking and Dupuytren's disease in a large cohort study (GAZEL). BMJ Open 2014, 4(1), e004214. https://doi.org/10.1136/bmjopen-2013-004214.Tajika, T.; Kobayashi, T.; Kaneko, T.; Tsunoda, D.; Tsunoda, K.; Sutou, T.; Yamamoto, A.; Takagishi, K. Epidemiological study for personal risk factors and quality of life related to Dupuytren's disease in a mountain village of Japan. J. Orthop. Sci. 2014, 19(1), 64-70. https://doi.org/10.1007/s00776-013-0478-y.Tajika, T.; Kobayashi, T.; Kaneko, T.; Tsunoda, D.; Tsunoda, K.; Sutou, T.; Yamamoto, A.; Takagishi, K. Epidemiological study for personal risk factors and quality of life related to Dupuytren's disease in a mountain village of Japan. J. Orthop. Sci. 2014, 19(1), 64-70. https://doi.org/10.1007/s00776-013-0478-y.Lai, M.C.; Lin, K.M.; Tsai, J.J.; Wu, Y.J.; Huang, C.W. Dupuytren's contracture: subacute onset after longterm antiepileptic drug use. Neuropsychiatry 2016, 6(6), 366-368. https://doi.org/10.4172/Neuropsychiatry.1000162.Lai, M.C.; Lin, K.M.; Tsai, J.J.; Wu, Y.J.; Huang, C.W. Dupuytren's contracture: subacute onset after longterm antiepileptic drug use. Neuropsychiatry 2016, 6(6), 366-368. https://doi.org/10.4172/Neuropsychiatry.1000162.MedlinePlus. Dupuytren contracture. Available online: https://medlineplus.gov/genetics/condition/dupuytren-contracture/ (accessed on 20 August 2022).MedlinePlus. Dupuytren contracture. Available online: https://medlineplus.gov/genetics/condition/dupuytren-contracture/ (accessed on 20 August 2022).Riesmeijer, S.A.; Werker, P.M.N.; Nolte, I.M. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants. Eur. J. Hum. Genet. 2019, 27, 1876–1884. https://doi.org/10.1038/s41431-019-0483-5.Riesmeijer, S.A.; Werker, P.M.N.; Nolte, I.M. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants. Eur. J. Hum. Genet. 2019, 27, 1876–1884. https://doi.org/10.1038/s41431-019-0483-5.Stahl, S.; Calif, E. Dupuytren's palmar contracture in women. Isr. Med. Assoc. J. 2008, 10(6), 445-447. https://pubmed.ncbi.nlm.nih.gov/18669144.Stahl, S.; Calif, E. Dupuytren's palmar contracture in women. Isr. Med. Assoc. J. 2008, 10(6), 445-447. https://pubmed.ncbi.nlm.nih.gov/18669144.Online Mendelian Inheritance in Man. Available online: https://www.omim.org/entry/126900 (accessed on 4 September 2022).Online Mendelian Inheritance in Man. Available online: https://www.omim.org/entry/126900 (accessed on 4 September 2022).Dupuytren Research Group. Available online: https://dupuytrens.org/common-dupuytren-disease/ (accessed on 4 September 2022).Dupuytren Research Group. Available online: https://dupuytrens.org/common-dupuytren-disease/ (accessed on 4 September 2022).Gudmundsson, K.G.; Arngrimsson, R.; Sigfusson, N.; Bjornsson, A.; Jonsson, T. Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik Study. J. Clin. Epidemiol. 2000, 53, 291–296. https://doi.org/10.1016/S0895-4356(99)00145-6.Gudmundsson, K.G.; Arngrimsson, R.; Sigfusson, N.; Bjornsson, A.; Jonsson, T. Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik Study. J. Clin. Epidemiol. 2000, 53, 291–296. https://doi.org/10.1016/S0895-4356(99)00145-6.Brenner, P.; Krause-Bergmann, A.; Van, V.H. Die Dupuytren-Kontraktur in Norddeutschland. Epidemiologische Erfassungsstudie anhand von 500 Fällen [Dupuytren contracture in North Germany. Epidemiological study of 500 cases]. Unfallchirurg 2001, 104(4), 303-311. https://doi.org/10.1007/s001130050732.Brenner, P.; Krause-Bergmann, A.; Van, V.H. Die Dupuytren-Kontraktur in Norddeutschland. Epidemiologische Erfassungsstudie anhand von 500 Fällen [Dupuytren contracture in North Germany. Epidemiological study of 500 cases]. Unfallchirurg 2001, 104(4), 303-311. https://doi.org/10.1007/s001130050732.Rehman, S.; Goodacre, R.; Day, P.J.; Bayat, A.; Westerhoff, H.V. Dupuytren's: a systems biology disease. Arthritis Res. Ther. 2011, 13(5), 238. https://doi.org/10.1186/ar3438.Rehman, S.; Goodacre, R.; Day, P.J.; Bayat, A.; Westerhoff, H.V. Dupuytren's: a systems biology disease. Arthritis Res. Ther. 2011, 13(5), 238. https://doi.org/10.1186/ar3438.Brown, J.J.; Ollier, W.; Thomson, W.; Bayat, A. Positive association of HLADRB1* 15 with Dupuytren's disease in Caucasians. Tissue Antigens 2008, 72, 166–170. https://doi.org/10.1111/j.1399-0039.2008.01082.x.Brown, J.J.; Ollier, W.; Thomson, W.; Bayat, A. Positive association of HLADRB1* 15 with Dupuytren's disease in Caucasians. Tissue Antigens 2008, 72, 166–170. https://doi.org/10.1111/j.1399-0039.2008.01082.x.Matthews, P. Familial Dupuytren's contracture with predominantly female expression. Br. J. Plast. Surg. 1979, 32(2), 120-123. https://doi.org/10.1016/0007-1226(79)90010-9.Matthews, P. Familial Dupuytren's contracture with predominantly female expression. Br. J. Plast. Surg. 1979, 32(2), 120-123. https://doi.org/10.1016/0007-1226(79)90010-9.Ranta, H.; Knif, J.; Ranta, K. Familial hypodontia associated with Dupuytren's disease. Scand. J. Dent. Res. 1990, 98(6), 457-460. https://doi.org/10.1111/j.1600-0722.1990.tb00999.x.Ranta, H.; Knif, J.; Ranta, K. Familial hypodontia associated with Dupuytren's disease. Scand. J. Dent. Res. 1990, 98(6), 457-460. https://doi.org/10.1111/j.1600-0722.1990.tb00999.x.Lyall, H.A. Dupuytren's disease in identical twins. J. Hand Surg. Br. 1993, 18(3), 368-370. https://doi.org/10.1016/0266-7681(93)90066-o.Lyall, H.A. Dupuytren's disease in identical twins. J. Hand Surg. Br. 1993, 18(3), 368-370. https://doi.org/10.1016/0266-7681(93)90066-o.Couch, H. Identical Dupuytren's contracture in identical twins. Can. Med. Assoc. J. 1938, 39(3), 225-226. https://pubmed.ncbi.nlm.nih.gov/20321080.Couch, H. Identical Dupuytren's contracture in identical twins. Can. Med. Assoc. J. 1938, 39(3), 225-226. https://pubmed.ncbi.nlm.nih.gov/20321080.Larsen, S.; Krogsgaard, D.G.; Aagaard Larsen, L.; Iachina, M.; Skytthe, A.; Frederiksen, H. Genetic and environmental influences in Dupuytren's disease: a study of 30,330 Danish twin pairs. J. Hand Surg. Eur. Vol. 2015, 40(2), 171-176. https://doi.org/10.1177/1753193414535720.Larsen, S.; Krogsgaard, D.G.; Aagaard Larsen, L.; Iachina, M.; Skytthe, A.; Frederiksen, H. Genetic and environmental influences in Dupuytren's disease: a study of 30,330 Danish twin pairs. J. Hand Surg. Eur. Vol. 2015, 40(2), 171-176. https://doi.org/10.1177/1753193414535720.What is the role of genetics in the etiology of Dupuytren contracture? Available online: https://www.medscape.com/answers/329414-164397/what-is-the-role-of-genetics-in-the-etiology-of-dupuytren-contracture (accessed on 16 September 2022).What is the role of genetics in the etiology of Dupuytren contracture? Available online: https://www.medscape.com/answers/329414-164397/what-is-the-role-of-genetics-in-the-etiology-of-dupuytren-contracture (accessed on 16 September 2022).Jung, J.; Kim, G.W.; Lee, B.; Joo, J.W.J.; Jang, W. Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren's disease. BMC Med. Genomics 2019, 12(Suppl 5), 98. https://doi.org/10.1186/s12920-019-0518-3.Jung, J.; Kim, G.W.; Lee, B.; Joo, J.W.J.; Jang, W. Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren's disease. BMC Med. Genomics 2019, 12(Suppl 5), 98. https://doi.org/10.1186/s12920-019-0518-3.Dupuytren’s contracture: the Viking disease explained. Available online: https://www.topdoctors.co.uk/medical-articles/dupuytren-s-contracture-the-viking-disease-explained (accessed on 16 September 2022).Dupuytren’s contracture: the Viking disease explained. Available online: https://www.topdoctors.co.uk/medical-articles/dupuytren-s-contracture-the-viking-disease-explained (accessed on 16 September 2022).Forrester, H.B.; Temple-Smith, P.; Ham, S.; de Kretser, D.; Southwick, G.; Sprung, C.N. Genome-Wide Analysis Using Exon Arrays Demonstrates an Important Role for Expression of Extra-Cellular Matrix, Fibrotic Control and Tissue Remodelling Genes in Dupuytren's Disease. PLoS ONE 2013, 8(3), e59056. https://doi.org/10.1371/journal.pone.0059056.Forrester, H.B.; Temple-Smith, P.; Ham, S.; de Kretser, D.; Southwick, G.; Sprung, C.N. Genome-Wide Analysis Using Exon Arrays Demonstrates an Important Role for Expression of Extra-Cellular Matrix, Fibrotic Control and Tissue Remodelling Genes in Dupuytren's Disease. PLoS ONE 2013, 8(3), e59056. https://doi.org/10.1371/journal.pone.0059056.Johnston, P.; Chojnowski, A.J.; Davidson, R.K.; Riley, G.P.; Donell, S.T.; Clark, I.M. A complete expression profile of matrixdegrading metalloproteinases in Dupuytren's disease. J. Hand Surg. Am. 2007, 32(3), 343-351. https://doi.org/10.1016/j.jhsa.2006.12.010.Johnston, P.; Chojnowski, A.J.; Davidson, R.K.; Riley, G.P.; Donell, S.T.; Clark, I.M. A complete expression profile of matrixdegrading metalloproteinases in Dupuytren's disease. J. Hand Surg. Am. 2007, 32(3), 343-351. https://doi.org/10.1016/j.jhsa.2006.12.010.

The authors declare that there are no conflicts of interest present.